Page last updated: 2024-10-30

mafenide and Brucellosis

mafenide has been researched along with Brucellosis in 1 studies

Mafenide: A sulfonamide that inhibits the enzyme CARBONIC ANHYDRASE and is used as a topical anti-bacterial agent, especially in burn therapy.

Brucellosis: Infection caused by bacteria of the genus BRUCELLA mainly involving the MONONUCLEAR PHAGOCYTE SYSTEM. This condition is characterized by fever, weakness, malaise, and weight loss.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Joseph, P1
Turtaut, F1
Ouahrani-Bettache, S1
Montero, JL1
Nishimori, I1
Minakuchi, T1
Vullo, D1
Scozzafava, A1
Köhler, S1
Winum, JY1
Supuran, CT1

Other Studies

1 other study available for mafenide and Brucellosis

ArticleYear
Cloning, characterization, and inhibition studies of a beta-carbonic anhydrase from Brucella suis.
    Journal of medicinal chemistry, 2010, Mar-11, Volume: 53, Issue:5

    Topics: Amino Acid Sequence; Animals; Base Sequence; Brucella suis; Brucellosis; Carbonic Anhydrases; Clonin

2010